| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $74.04 | $17.59 | 320.92% | 308.50x | 21.68x | 22.62x | 60.64x | 1.52x | $41.15M | 0.63% | $108.58M | 1.23 | $6.54B | 122.14 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $288.18 | $93.15 | 209.36% | 66.10x | 38.21x | 8.93x | 35.78x | 1.37x | $641.34M | 1.67% | $1.08B | 8.09 | $39.74B | 42.98 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $7.20 | $2.91 | 147.14% | 102.86x | 67.23x | 3.90x | 95.54x | 0.95x | $47.52M | 3.88% | $13.01M | 0.08 | $1.39B | 26.01 | ||
| CORT | CORCEPT THERAPEUTICS INC | $79.85 | $20.67 | 286.36% | 173.59x | 152.50x | 10.84x | 13.44x | 1.46x | $119.79M | 1.44% | $637.99M | 6.11 | $8.47B | -1,234.04 | ||
| KRYS | KRYSTAL BIOTECH INC | $340.21 | $95.01 | 258.07% | 43.90x | 42.79x | 23.88x | 7.86x | 2.10x | $237.38M | 2.38% | $1.28B | 43.59 | $9.54B | 44.57 | ||
| HALO | HALOZYME THERAPEUTICS INC | $69.62 | $71.06 | -2.03% | 23.52x | 8.40x | 5.45x | 37.60x | 0.42x | $667.65M | 8.12% | $219.64M | 1.86 | $10.09B | 16.18 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $59.49 | $17.25 | 244.79% | 60.70x | 46.60x | 6.04x | 7.56x | 1.64x | $164.23M | 3.61% | $605.69M | 7.92 | $4.40B | 39.43 | ||
| RPRX | ROYALTY PHARMA PLC | $55.35 | $39.73 | 39.32% | 28.98x | 10.38x | 9.91x | 3.21x | 0.62x | $2.34B | 9.68% | $9.94B | 22.75 | $40.24B | 34.59 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $13.00 | $15.90 | -18.26% | 6.34x | 27.12x | 6.21x | 3.73x | 0.85x | $56.42M | 7.43% | $205.80M | 3.52 | $674.05M | 4.66 | ||
| VCEL | VERICEL CORP | $40.39 | $9.10 | 343.81% | 93.93x | 83.78x | 7.02x | 5.79x | 1.98x | $47.49M | 2.31% | $356.23M | 7.02 | $2.05B | 50.67 | ||
| ADMA | ADMA BIOLOGICS INC | $8.69 | $9.65 | -9.96% | 12.59x | 9.50x | 4.02x | 5.16x | 0.48x | $107.90M | 5.26% | $390.33M | 1.65 | $2.07B | 9.36 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.50 | $41.62 | 35.76% | 40.36x | 14.90x | 3.35x | 1.76x | 0.55x | $767.06M | 7.05% | $6.21B | 32.27 | $9.28B | 19.23 | ||
| ASND | ASCENDIS PHARMA A | $238.59 | $80.38 | 196.83% | 25.29x | 16.00x | 14.55x | 25.81x | 2.59x | $52.94M | 0.36% | $574.09M | 9.24 | $15.20B | 163.00 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $230.25 | $49.21 | 367.90% | 489.89x | 8.95x | 3.21x | 3.19x | 1.65x | $1.30B | 9.11% | $4.53B | 73.22 | $18.00B | 26.67 | ||
| TECH | BIO-TECHNE CORP | $56.26 | $15.26 | 268.69% | 79.24x | 28.68x | 7.26x | 4.22x | 1.63x | $269.60M | 3.07% | $2.09B | 13.34 | $8.89B | 34.73 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.16 | $35.61 | -4.06% | 13.50x | 9.28x | 2.20x | 2.17x | 0.51x | $341.79M | 17.30% | $910.35M | 15.75 | $1.55B | 6.53 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $279.44 | $94.02 | 197.23% | 35.37x | 30.79x | 20.24x | 5.62x | 1.78x | $122.22M | 2.20% | $997.32M | 50.16 | $5.94B | 26.32 | ||
| TGTX | TG THERAPEUTICS INC | $53.94 | $16.97 | 217.89% | 16.75x | 38.56x | 11.12x | 14.16x | 265.45x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.57B | 57.10 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.15 | $5.71 | -62.36% | 7.96x | 3.15x | 2.01x | 2.35x | 0.17x | $7.24M | 5.86% | $52.93M | 0.92 | $70.83M | 4.57 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $468.42 | $167.27 | 180.04% | 27.54x | 23.96x | 9.74x | 6.14x | 2.01x | $3.71B | 3.12% | $19.36B | 76.20 | $115.38B | 21.39 | ||
| UTHR | UNITED THERAPEUTICS CORP | $544.33 | $242.28 | 124.67% | 18.59x | 19.13x | 7.47x | 3.92x | 2.06x | $1.02B | 4.29% | $5.90B | 135.66 | $21.83B | 12.74 | ||
| EXEL | EXELIXIS INC | $51.34 | $30.72 | 67.10% | 16.46x | 15.59x | 5.58x | 6.67x | 1.20x | $917.69M | 6.92% | $1.94B | 7.49 | $12.85B | 12.17 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.38 | $2.45 | 37.96% | 14.08x | 14.29x | 2.07x | 3.27x | 0.95x | $4.11M | 1.51% | $82.33M | 1.03 | $205.22M | 9.66 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $618.03 | $434.28 | 42.31% | 14.52x | 13.14x | 4.31x | 2.06x | 0.98x | $4.11B | 6.40% | $31.42B | 302.15 | $64.54B | 11.23 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.40 | $12.20 | 157.39% | 17.35x | 16.01x | 6.43x | 3.79x | 3.89x | $208.13M | 5.42% | $1.01B | 8.28 | $3.09B | 9.22 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.17 | $1.26 | 72.88% | 11.42x | 9.99x | 2.27x | 2.60x | 2.82x | $13.00M | 7.51% | $67.23M | 0.84 | $141.61M | 6.34 | ||
| INCY | INCYTE CORP | $104.40 | $66.60 | 56.76% | 14.32x | 13.33x | 3.88x | 3.71x | 1.23x | $1.45B | 6.97% | $5.62B | 28.21 | $17.43B | 9.32 | ||
| VCYT | VERACYTE INC | $53.79 | $7.57 | 610.54% | 48.46x | 48.23x | 7.90x | 3.19x | 10.32x | $155.34M | 3.63% | $1.34B | 16.90 | $4.07B | 35.35 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.26 | $3.59 | 380.39% | 28.77x | 4.71x | 0.83x | 1.21x | 13.02x | $109.24M | 6.03% | $1.51B | 14.34 | $2.39B | 28.94 | ||
| MDXG | MIMEDX GROUP INC | $3.73 | $1.25 | 198.40% | 17.76x | -44.30x | 1.42x | 2.29x | 8.45x | $69.36M | 12.52% | $242.94M | 1.64 | $413.39M | 7.59 |